|
|
Novartis AG CDR
TSX •
Healthcare •
Drug Manufacturers - General •
Quote as of 10/30/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeTSX
Market Capitalization389,264 mln
Float1,608 mln
Earnings Date10/27/2026
Key Fundamentals
EPS1.02
P/E31.26
ROE29.85
ROIC12.08
ROA11.16
Interest Cover11.66
EBITDA, mln31,105
EV / EBITDA15.82
EV / EBIT20.68
Revenue, mln78,520
EV / Revenue6.39
Quote Details
Last
31.89
Change
0.23 (0.73%)
Open
31.89
Volume
206
Turnover
6,569.34
Average Volume
962.19
Financial Ratios
Pre-Tax Profit Margin28
Leverage Ratio2.94
Current Ratio0.86
Price / Book7.03
Price / Cash Flow16.40
Price / Free Cash Flow18.76
Debt / Equity1.18
Price / Sales5.70
PEG Ratio2.38
Financial Strength
Altman Z-Score3.47
Piotroski F-Score
5
/ 9
Beneish M-Score-2.57
Price to Intrinsic Value1.72
Shiller PE Ratio24.15
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
7.34% |
98
/ 100
 |
| 1 Month |
12.85% |
94
/ 100
 |
| 2 Months |
10.84% |
85
/ 100
 |
| 6 Months |
11.82% |
79
/ 100
 |
|
| |
